Commonwealth Equity Services, LLC Co Diagnostics, Inc. Transaction History

Commonwealth Equity Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$8.52 - $19.21 $197,732 - $445,825	-23,208 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$9.3 - $15.19 $609,289 - $995,172	-65,515 Reduced 73.84%	23,208 $215,000
Q3 2020 Nov 05, 2020	BUY	$8.24 - $30.8 $592,126 - $2.21 Million	71,860 Added 426.14%	88,723 $1.21 Million
Q2 2020 Aug 12, 2020	BUY	$7.46 - $23.42 $22,663 - $71,149	3,038 Added 21.97%	16,863 $326,000
Q1 2020 May 11, 2020	BUY	$0.91 - $17.81 $12,580 - $246,223	13,825 New	13,825 $105,000

4.29M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $25M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.